30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Strategic Initiatives

aap Implantate entered into a definitive agreement under which a private equity firm will acquire its European Medical Contract Manufacturing (EMCM) business for €18MM (~US $24.7MM) in cash. Closing will occur in 1Q14. The transaction supports the company’s strategy to focus on its trauma and acrylic bone cement businesses. EMCM manufactures sterile medicinal products for the biomaterials, pharmaceuticals and tissue engineering markets. (aap Implantate AG, 2/24/14)